A number of studies in this area have confirmed that EGCG has the capability to hinder the growth of cells in prostate cancer, diminish the levels of androgen receptors within prostate cancer cells, suppress the secretion of PSA by them, trigger the death of such cells, and weaken the resistance of prostate cancer to Flu [26]. The gene discussed is KLK3; the disease is prostate carcinoma.